Key result
Tissue engineering constructs show less calcification than pericardial controls in preclinical models.
Why the study?
Heart valve tissue engineering requires proper scaffold design to assess and mitigate material-related risks like calcific nodule formation, prompting the establishment of an in vitro model to evaluate calcification risk.
Polymeric tissue engineering scaffolds exhibit significantly less calcification than bovine pericardial patches in a novel 3D in vitro model, supporting their development for heart valve regeneration.
TE scaffolds merit further preclinical valve studies; leaves open clinical translation.
Purpose: Material driven in situ heart valve tissue engineering (HVTE) prospects an alternative to non-living replacements. HVTE exploits bioresorbable (synthetic) scaffolds that guide neo-tissue formation. Proper scaffold design assesses and mitigates potential material-related risks, such as calcific nodule formation. Herein, we establish an in vitro model to investigate the calcification risk of materials for HVTE. Methods: Calcification was studied by culturing 3D scaffolds with porcine valvular interstitial cells in a phosphate-enhanced calcification medium (CM) for 3 weeks. The model was applied by testing three electrospun polymeric Tissue engineering (TE) scaffolds (PCL, PCL-BU, and PC-BU) against a bovine pericardial patch control. Additionally, the model included a 10% cyclic strain environment to evaluate hemodynamic effects. Results: TE constructs showed significantly less calcification compared to the pericardial tissue control, mirroring in vivo animal model findings. No differences in calcification were observed among the TE constructs, and cyclic strain did not affect calcification. Conclusion: The 3D in vitro model established in this study effectively mimics calcification in TE material constructs, aiding in systematic testing and comparison of cardiovascular TE materials. It can help understand calcification principles and evaluate potential risk factors (e.g., strain). As such, the model will support the design of biomaterials for in situ HVTE in particular and implantable polymer grafts in general. Supplementary Information: The online version contains supplementary material available at 10.1007/s44164-025-00090-x.
No takes yet. Share an insight, caveat, or question.
Valk et al. (2025) studied Calcific aortic heart valve disease. Polymeric Tissue engineering (TE) scaffolds (PCL, PCL-BU, and PC-BU) vs. Bovine pericardial patch control was evaluated on Calcification. Tissue engineering constructs showed significantly less calcification compared to the pericardial tissue control, mirroring in vivo animal model findings.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: